International Business News - UTHR http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE http://www.ibtimes.com/articles/20081117/target-citigroup-lowes-among-big-movers.htm Mon, 17 Nov 2008 17:42:25 EST In early trading Monday, United Therapeutics Corp. (Nasdaq:UTHR) shares fell more than 30 percent on Monday after it said one of its treatments in the FREEDOM-C RIAL did not meet its main goal of median change in the distance covered in a six-minute walk at 16 weeks relative to baseline. http://www.ibtimes.com/articles/20081117/top-decliner-united-therapeutics-trial-misses-goal-shares-down-pct.htm Mon, 17 Nov 2008 11:11:18 EST Shares of United Therapeutics Corp. plunged Monday after the company said a new formulation of its hypertension drug Remodulin failed to meet its goal in a late-stage study. http://www.ibtimes.com/articles/20081117/united-therapeutics-shares-plunge-on-failed-study.htm Mon, 17 Nov 2008 12:01:55 EST Biotechnology company United Therapeutics Corp. said Monday it is licensing rights to sell Eli Lilly & Co.'s erectile dysfunction drug Cialis as a hypertension treatment in the U.S. http://www.ibtimes.com/articles/20081117/united-therapeutics-eli-lilly-sign-drug-contract.htm Mon, 17 Nov 2008 08:19:57 EST Biotechnology company United Therapeutics Corp. said Monday an oral sustained-release version of its hypertension drug Remodulin failed a late-stage study. http://www.ibtimes.com/articles/20081117/united-therapeutics-hypertension-drug-fails-study.htm Mon, 17 Nov 2008 10:13:26 EST Standard & Poor's says it will remove Fannie Mae and Freddie Mac from the S&P 500 after close of trading Wednesday, following a dramatic drop in the mortgage giants' stock prices. http://www.ibtimes.com/articles/20080909/fannie-mae-and-freddie-mac-removed-from-s-p-500.htm Tue, 09 Sep 2008 18:30:45 EDT A buyout bull's-eye will likely remain on biotechnology companies over the next few years as major pharmaceutical companies continue taking advantage of a weak dollar and a surplus of cash to buy pipeline additions. http://www.ibtimes.com/articles/20080820/biotech-buyout-action-likely-to-continue.htm Wed, 20 Aug 2008 11:41:33 EDT Standard & Poor's Inc. included 10 U.S. health care companies among 73 companies based in the U.S. that made its annual Global Challengers, a list released Wednesday of midsized companies that show the "highest growth characteristics." http://www.ibtimes.com/articles/20080723/s-p-names-10-us-health-companies-as-likely-to-grow.htm Wed, 23 Jul 2008 16:41:13 EDT Large-cap biotech stocks are better positioned to bring investors returns during the second half of 2008 due to revenue gains and development deals, J.P. Morgan analysts said Tuesday. http://www.ibtimes.com/articles/20080624/sector-snap-biotech-_-large-cap-or-small-cap.htm Tue, 24 Jun 2008 12:51:24 EDT The chairman and chief executive of United Therapeutics Corp. exercised options for 7,200 shares of common stock under a prearranged trading plan, according to a Securities and Exchange Commission filing. http://www.ibtimes.com/articles/20080620/united-therapeutics-ceo-exercises-options.htm Fri, 20 Jun 2008 13:59:09 EDT The chairman and chief executive of United Therapeutics Corp. exercised options for 12,200 shares of common stock under a prearranged trading plan, according to a Securities and Exchange Commission filing. http://www.ibtimes.com/articles/20080613/united-therapeutics-ceo-exercises-options.htm Fri, 13 Jun 2008 13:22:52 EDT The chairman and chief executive of United Therapeutics Corp. exercised options for 12,200 shares of common stock under a prearranged trading plan, according to a Securities and Exchange Commission filing. http://www.ibtimes.com/articles/20080527/united-therapeutics-chairman-ceo-exercises-options.htm Tue, 27 May 2008 12:10:12 EDT Shares of United Therapeutics Corp. rose Thursday after data showed that an inhaled version of its drug candidate to treat pulmonary arterial hypertension met its goal in a late-stage trial. http://www.ibtimes.com/articles/20080522/united-therapeutics-shares-rise-on-viveta-data.htm Thu, 22 May 2008 18:27:21 EDT While the stock performance of large biotech stocks such as Genentech Inc. and Amgen Inc. have disappointed investors over the last year, several lesser-known companies have bucked the trend and demonstrated that sometimes, smaller is better. http://www.ibtimes.com/articles/20080521/smaller-biotechs-shine-while-big-names-disappoint.htm Wed, 21 May 2008 16:46:19 EDT Shares of United Therapeutics Corp. rose Thursday after the biotechnology company said it swung to a first-quarter profit, helped by sales of its blood-pressure treatment and lower research and development costs. http://www.ibtimes.com/articles/20080501/united-therapeutics-shares-rise-after-co-swings-to-profit.htm Thu, 01 May 2008 19:02:28 EDT